Age Rating
Cancer Risk スクリーンショット
About Cancer Risk
The Rotterdam Prostate Cancer Risk Calculator is based on ERSPC, Rotterdam, data and supported by the Prostate Cancer Research Foundation, Rotterdam (SWOP)
The Prostate Cancer Research Foundation, Rotterdam, Stichting Wetenschappelijk Onderzoek Prostaatkanker (SWOP), is an initiative of the Department of Urology of the Erasmus MC, the University and Medical Centre of Rotterdam, in The Netherlands. Its goal is the financial support of scientific research projects in the field of prostate cancer, as well as other cancers of the urinary tract.
Please be aware that the Rotterdam Prostate Cancer Risk Calculator for iOS cannot be 100% accurate at predicting the presence or absence of prostate cancer. It is designed to help calculate your risk, not give a definitive diagnosis.
The Rotterdam Prostate Cancer Risk Calculator for iOS provides a general risk calculation based on your PSA level and other information.
While knowing your PSA level is helpful, the decision to have a PSA test has to be taken seriously after weighing up all factors and discussing the implications with your GP or hospital doctor.
It is possible that prostate cancer will not be found even if you have an elevated PSA. However, it may be present even if your PSA level is low.
Your doctor may want to take further tests. If you have doubts or questions about your health, you should always contact your GP or hospital doctor. This is particularly important if you have questions which arise from the use of our prostate cancer risk calculator.
It cannot be ruled out that the way the Rotterdam Prostate Cancer Risk Calculator for iOS is used, or the indications given by it, are interpreted in a manner that is not appropriate. The creators of the Rotterdam Prostate Cancer Risk Calculator for iOS do not accept any responsibility in any respect.
The European Randomized Study of Screening for Prostate Cancer has published its 11-year follow-up results (New England Journal of Medicine, March 15 2012). Once again, they demonstrate that screening does significantly reduce death from prostate cancer. The latest study confirms that a man who undergoes PSA testing will have his risk of dying from prostate cancer reduced by 29%.
ERSPC is the world’s largest randomized prostate cancer screening study. It was designed to investigate whether early detection and treatment of prostate cancer might reduce disease-specific mortality and also help to identify men at risk. From 1992, the ERSPC study randomized 162,000 men, aged 55 to 69, across Europe to either a screening arm or a control group.
Designed and developed for iOS by Nuno Azevedo of Ydeal.net Software LDA
The Prostate Cancer Research Foundation, Rotterdam, Stichting Wetenschappelijk Onderzoek Prostaatkanker (SWOP), is an initiative of the Department of Urology of the Erasmus MC, the University and Medical Centre of Rotterdam, in The Netherlands. Its goal is the financial support of scientific research projects in the field of prostate cancer, as well as other cancers of the urinary tract.
Please be aware that the Rotterdam Prostate Cancer Risk Calculator for iOS cannot be 100% accurate at predicting the presence or absence of prostate cancer. It is designed to help calculate your risk, not give a definitive diagnosis.
The Rotterdam Prostate Cancer Risk Calculator for iOS provides a general risk calculation based on your PSA level and other information.
While knowing your PSA level is helpful, the decision to have a PSA test has to be taken seriously after weighing up all factors and discussing the implications with your GP or hospital doctor.
It is possible that prostate cancer will not be found even if you have an elevated PSA. However, it may be present even if your PSA level is low.
Your doctor may want to take further tests. If you have doubts or questions about your health, you should always contact your GP or hospital doctor. This is particularly important if you have questions which arise from the use of our prostate cancer risk calculator.
It cannot be ruled out that the way the Rotterdam Prostate Cancer Risk Calculator for iOS is used, or the indications given by it, are interpreted in a manner that is not appropriate. The creators of the Rotterdam Prostate Cancer Risk Calculator for iOS do not accept any responsibility in any respect.
The European Randomized Study of Screening for Prostate Cancer has published its 11-year follow-up results (New England Journal of Medicine, March 15 2012). Once again, they demonstrate that screening does significantly reduce death from prostate cancer. The latest study confirms that a man who undergoes PSA testing will have his risk of dying from prostate cancer reduced by 29%.
ERSPC is the world’s largest randomized prostate cancer screening study. It was designed to investigate whether early detection and treatment of prostate cancer might reduce disease-specific mortality and also help to identify men at risk. From 1992, the ERSPC study randomized 162,000 men, aged 55 to 69, across Europe to either a screening arm or a control group.
Designed and developed for iOS by Nuno Azevedo of Ydeal.net Software LDA
Show More
最新バージョン 3.2.3 の更新情報
Last updated on 2020年09月22日
旧バージョン
Bug Fixed
Show More
Version History
3.2.3
2020年09月22日
Bug Fixed
3.2.2
2020年07月22日
Update About
3.2.1
2020年05月05日
Bug Fixed
3.2.0
2020年04月01日
Calculation improvement
3.1.2
2019年04月10日
New About
3.1.1
2018年10月13日
Add information
3.1.0
2018年09月04日
MRI is short for Magnetic Resonance Imaging. A MRI of the prostate is graded according the PIRADS system where PIRADS 1 relates to benign disease and PIRADS 5 to a more aggressive malignancy. For this risk calculator PIRADS version 1 was used.
2.6.6
2018年03月01日
Bug fixed
2.6.5
2018年01月12日
Bug fixed
2.6.4
2018年01月11日
Bug fix
2.6.3
2018年01月05日
support for iPhone X and bug fix
2.6.2
2017年11月04日
support for iPhone X
2.6.1
2016年11月29日
Bug fixed - Estonian language
2.6
2016年09月26日
Includes support for Estonian language
2.5
2015年10月29日
In-App language selection;
Send your results by email to your doctor.
Send your results by email to your doctor.
2.1
2014年10月20日
Minor issues fixed.
Add Chinese, Spanish and Portuguese languages.
Add Chinese, Spanish and Portuguese languages.
2.0
2014年04月03日
Add iPad support and improve performance.
1.2
2013年12月05日
This version is now compatible with previous iOS versions (pre-iOS7).
1.1
2013年11月10日
Updated algorithm!
1.0
2013年10月25日
Cancer Risk 価格
今日:
¥300
最低価格:
¥300
最高価格:
¥320
Cancer Risk FAQ
ここをクリック!地理的に制限されているアプリのダウンロード方法をご参考ください。
次のリストをチェックして、Cancer Riskの最低システム要件をご確認ください。
iPhone
iOS 9.3以降が必要です。
iPad
iPadOS 9.3以降が必要です。
iPod touch
iOS 9.3以降が必要です。
Cancer Riskは次の言語がサポートされています。 エストニア語, オランダ語, スペイン語, ドイツ語, ポルトガル語, 簡体字中国語, 英語